Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydrocortisone sodium succin 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 100mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 250mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 500mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 1000mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 100mg/2 mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 250mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 500mg/4mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 1000mg/8mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succin 100mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succinate 100mg/vial powder for injection 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succinate 500mg/vial powder for injection 4mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succinate 1000mg/vial powder for injection 8mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone sodium succinate 250mg/vial powder for injection 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
|
Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
1 |
Hydrocortisone (as hydrocortisone sodium succinate) 100 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone (as hydrocortisone sodium succinate) 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hydrocortisone sodium succinate |
Inferred relationship |
Some |
1 |